Introduction: Acne vulgaris is the most common skin condition worldwide, and it is associated with substantial psychological comorbidity. Topical therapies - including retinoids, antibiotics, and benzoyl peroxide - are the cornerstones of treatment for patients with acne. The main barriers to care in the treatment of acne are poor adherence to therapy and lack of tolerability.
Areas Covered: Herein, the authors review the safety and efficacy of adapalene/benzoyl peroxide combination gel (0.1%/2.5% and 0.3%/2.5%), as well as its specific mechanisms of action that target acne vulgaris. The authors also offer an expert opinion on the use of adapalene/benzoyl peroxide gel compared with other topical therapies.
Expert Opinion: Adapalene/benzoyl peroxide gel is safe and highly effective in the treatment of acne vulgaris. Its efficacy, tolerability, and ease-of-use are superior to other topical acne therapies, and its use does not contribute to antibiotic resistance. However, the cost of adapalene/benzoyl peroxide gel and lack of available generics may prohibit its use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14656566.2021.1939678 | DOI Listing |
Cochrane Database Syst Rev
October 2024
Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Cureus
September 2024
Public Health, Health Services Academy, Islamabad, PAK.
Arch Dermatol Res
September 2024
Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Ital J Dermatol Venerol
August 2024
Department of Dermatology, Seoul National University College of Medicine, Seoul, South Korea -
J Eur Acad Dermatol Venereol
June 2024
The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York, USA.
Acne is a common skin condition, but little data exist on the comparative efficacy of topical acne therapies. We conducted a systematic review and network meta-analysis to evaluate the efficacy of topical therapies for mild-to-moderate acne. Searches in PubMed/MEDLINE, Cochrane CENTRAL via Ovid, Embase via Ovid and Web of Science were conducted on 29 November 2021.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!